Korro Bio News

Korro Bio | 8-K: Current report

Nov 4 20:34

Korro Bio | 8-K: Current report

Sep 16 20:06

Korro Bio | 8-K: Current report

Aug 29 04:13

Korro Bio | 8-K: Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates

Aug 14 04:08

Korro Bio | 8-K: Current report

Jun 22 04:17

Korro Bio | 8-K: Current report

Jun 13 04:08

Korro Bio | S-1: General form for registration of securities under the Securities Act of 1933

May 15 04:40

Korro Bio | 8-K: Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer

May 15 04:08

Korro Bio | 8-K: Current report

May 15 04:08

Korro Bio | DEFA14A: Others

May 2 05:22

Korro Bio | DEFA14A: Others

Apr 29 19:48

Korro Bio | DEF 14A: Definitive information statements

Apr 29 19:48

Korro Bio | 8-K: Current report

Apr 23 05:12

Korro Bio | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 20 04:11

Korro Bio | 8-K: Current report

Apr 18 20:46

Korro Bio | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 27 05:15

Korro Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 27 05:06

Korro Bio | 8-K: Current report

Mar 27 04:23

Korro Bio | 8-K: Current report

Jan 9 13:00

Korro Bio | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Dec 21, 2023 05:44